Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03695120 · ClinicalTrials.gov registry record · NA
RAAS Optimization for Acute CHF Patients
A NA study of Acute Decompensated Heart Failure, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT03695120: Completed NA study of Acute Decompensated Heart Failure, sponsored by University of Florida.
NCT03695120 is a NA study of Acute Decompensated Heart Failure that has completed, run by University of Florida. The registered enrollment target is 1 participants, below the 459-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03695120, a NA study of Acute Decompensated Heart Failure, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
Holding ACEI/ARBs during initial 72 hours of admission with acute decompensated heart failure may help preserve renal function with a lesser decline in GFR. This treatment modification will also allow the option of aggressive diuresis in volume overloaded CHF patients which should result in a lesser decline of AKI, length of stay, readmission rates, and cost associated with CHF treatment.
Primary Outcome
Change in serum creatinine from randomization. (AKI is defined as an increase in the serum creatinine level of more than 0.3 mg per deciliter over 48 hours)
Conditions Studied
Interventions
- OTHER Change of treatment plan
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2021-04-12 |
| Phase | NA |
What the finished NCT03695120 record still lists
NCT03695120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 459-participant average among 12 other Acute Decompensated Heart Failure trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Acute Decompensated Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Change of treatment plan is the first listed.
NCT03695120 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03695120 about?
NCT03695120 is a clinical study titled "RAAS Optimization for Acute CHF Patients". Holding ACEI/ARBs during initial 72 hours of admission with acute decompensated heart failure may help preserve renal function with a lesser decline in GFR. This treatment modification will also allow the option of aggressive diuresis in volume overloaded CHF patients which should result in a lesser...
What is the current status of trial NCT03695120?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2019-02-08. Estimated completion is 2021-04-12.
What conditions does trial NCT03695120 study?
This clinical trial studies the following conditions: Acute Decompensated Heart Failure.
What interventions are being tested in trial NCT03695120?
The interventions under investigation include: Change of treatment plan (OTHER).
Who is sponsoring clinical trial NCT03695120?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03695120 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Decompensated Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03695120's enrollment target sits among peer trials
1 13th of 12 the lowest of 12 other Acute Decompensated Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Decompensated Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
RECRUITING · NA
-
DORAYA-HF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)
COMPLETED · NA
-
Evaluation of Cardiopulmonary Diseases by Ultrasound
COMPLETED · NA
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI